Big-Pharma Novartis to Charge $475,000 for $20,000 Cancer Cure Funded by Taxpayers and Charity

Big-Pharma Novartis to Charge $475,000 for $20,000 Cancer Cure Funded by Taxpayers and Charity

 By Tony Cartalucci

While Americans squabble over irrelevant political diversions, a
revolutionary breakthrough in human healthcare has yielded its first FDA
approval – a therapy that literally cures otherwise incurable leukemia.

It is the first of many therapies that re-engineer human cells in
living patients to reprogram more resilient immune systems and even
repair damaged or aging organs.